We are live on
!
Find out more
ABI
Abrams Bison Investments Portfolio holdings
AUM
$2.31B
1-Year Est. Return
40.26%
This Fund
S&P 500
This Quarter
Est. Return
+5.93%
1 Year Est. Return
+40.26%
3 Year Est. Return
+102.77%
5 Year Est. Return
+145.65%
10 Year Est. Return
+699.49%
AUM
$965M
AUM Growth
+$65.6M
(+7.3%)
Cap. Flow
+$25.6M
Cap. Flow
% of AUM
2.65%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
1
Increased
–
Reduced
1
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Acadia Healthcare
ACHC
|
+$77.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Credit Acceptance
CACC
|
+$39.7M |
| 2 |
Interactive Brokers
IBKR
|
+$11.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 31.78% |
| 2 | Healthcare | 28.06% |
| 3 | Technology | 22.28% |
| 4 | Consumer Discretionary | 9.8% |
| 5 | Energy | 8.09% |
Similar funds
NDSIB
EPM
CM
NSAM
BWFA
FBIL
LFM
MAP
Abrams Bison Investments's Q2 2019 Portfolio in Review
As of Q2 2019, Abrams Bison Investments held 9 positions worth $965M, up 7.3% from $899M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Abrams Bison Investments's Q2 2019 filing shows 1 new, 1 reduced and 1 closed positions. Its largest new stake was Acadia Healthcare: 2,390,000 shares worth $83.5M. The largest sale was Credit Acceptance, an estimated $39.7M.
By sector, the portfolio is most concentrated in Financials at 32% of assets, down from 36% a quarter earlier, followed by Healthcare and Technology.
- Abrams Bison Investments's largest Q2 2019 buy was Acadia Healthcare: 2,390,000 shares worth $83.5M.
- Abrams Bison Investments's biggest Q2 2019 reduction was Credit Acceptance, cutting an estimated $39.7M.
- Abrams Bison Investments fully exited Interactive Brokers in Q2 2019, selling an estimated $11.9M.
- Abrams Bison Investments's ten largest holdings make up 100% of its $965M portfolio in Q2 2019.
- Abrams Bison Investments opened 1 new position and closed 1 in Q2 2019.
- Abrams Bison Investments's portfolio value rose 7.3% quarter-over-quarter to $965M.
Based on Abrams Bison Investments's 13F filing for Q2 2019, filed 14 Aug 2019.